Multiple sclerosis Home - About Antigenics - Disease Areas - Multiple sclerosis What is multiple sclerosis?
HEMISPHERX BIOPHARMA LAUNCHES MULTIPLE SCLEROSIS SALVAGE PROGRAM WITH NATURAL INTERFERONS Urgent Clinical Need for Alternative (AMEX: HEB) announced today that it submitted to the FDA a new clinical Protocol entitled “ A multi-center, open label, study of Alferon N Injection® in subjects with relapsing-remitting multiple sclerosis, who have discontinued interferon -beta therapy because of clinical progression or intolerance, or who have developed neutralizing antibodies to interferon ...
Interferon for genital warts (human papillomavirus) - [Medication] - Quest Diagnostics Patient Health Library Interferon for genital warts (human papillomavirus) Examples Brand Name Chemical Name Roferon-A interferon alfa-2a Intron A interferon alfa-2b Alferon N interferon alfa-n3 Betaseron interferon beta -1b Actimmune interferon gamma-1b How It Works Interferon can kill viruses and prevent them from reproducing; it also...
Interferon beta for multiple sclerosis - [Medication] - Quest Diagnostics Patient Health Library Interferon beta for multiple sclerosis Examples Brand Name Chemical Name Avonex, Rebif, Betaseron interferon beta How It Works The interferon beta medications resemble the natural interferon the body produces during a response by the immune system to disease.
Chiron Corporation - Business - Business Units - Chiron BioPharmaceuticals Leading products include TOBI® tobramycin solution for inhalation, PROLEUKIN® (aldesleukin) interleukin-2 and BETASERON ® INTERFERON BETA -1b.
Chiron Corporation - Physicians - History & Milestones For more than 20 years, Chiron has been an industry leader, making groundbreaking scientific discoveries and creating revolutionary products that are improving human health worldwide.BETASERON ® INTERFERON BETA -1b gains expanded U.S.
Chiron Corporation - Research - History - - For more than 20 years, Chiron has been an industry leader, making groundbreaking scientific discoveries and creating revolutionary products that are improving human health worldwide.BETASERON ® INTERFERON BETA -1b gains expanded U.S.
Chiron Media Kit page 16
author: Chiron Corporation
subject: For your convenience, printable versions of key information from various sections of our corporate site can be found here in PDF format. To the best of Chiron s knowledge, all information included is timely and accurate as of the date originally issued.
duplicates:http://www.chiron.com/media/mediakit/media_fact_sheet.pdf
Chiron Media Kit page 2
author: Chiron Corporation
subject: For your convenience, printable versions of key information from various sections of our corporate site can be found here in PDF format. To the best of Chiron s knowledge, all information included is timely and accurate as of the date originally issued.
duplicates:http://www.chiron.com/media/mediakit/media_chiron_history.pdf
Chiron Media Kit Howard Pien Chief Executive Officer and Chairman of the Board, Chiron Corporation Raymund Breu, Ph.BETASERON ® INTERFERON BETA - 1b gains expanded U.BETASERON ® , the first treatment for relapsing- remitting multiple sclerosis, approved in United States.
author: Chiron Corporation
subject: For your convenience, printable versions of key information from various sections of our corporate site can be found here in PDF format. To the best of Chiron s knowledge, all information included is timely and accurate as of the date originally issued.
Chiron Fact Sheet Through its global Blood Testing, Vaccines and BioPharmaceuticals businesses, Chiron Corporation addresses human suffering with more than 50 diverse products to detect, prevent and treat disease worldwide.
author: Chiron Corporation
subject: For your convenience, printable versions of key information from various sections of our corporate site can be found here in PDF format. To the best of Chiron s knowledge, all information included is timely and accurate as of the date originally issued.
Chiron History For more than 20 years, Chiron has been an industry leader, making groundbreaking scientific discoveries and creating revolutionary products that are improving human health worldwide.BETASERON ® INTERFERON BETA - 1b gains expanded U.
author: Chiron Corporation
subject: For your convenience, printable versions of key information from various sections of our corporate site can be found here in PDF format. To the best of Chiron s knowledge, all information included is timely and accurate as of the date originally issued.
Chiron Corporation - Media - Fact Sheet Through its global Blood Testing, Vaccines and BioPharmaceuticals businesses, Chiron Corporation addresses human suffering with more than 50 diverse products to detect, prevent and treat disease worldwide.
Chiron Corporation - Media - Chiron History For more than 20 years, Chiron has been an industry leader, making groundbreaking scientific discoveries and creating revolutionary products that are improving human health worldwide.BETASERON ® INTERFERON BETA -1b gains expanded U.S.
Chiron Corporation - Research - Partnerships - - In addition to the company's own research and development activities, Chiron develops technology and products in collaboration with several leading companies.
Chiron Corporation - Business - Partnerships - - In addition to the company's own research and development activities, Chiron develops technology and products in collaboration with several leading companies.
Chiron Corporation - About Us - History - - For more than 20 years, Chiron has been an industry leader, making groundbreaking scientific discoveries and creating revolutionary products that are improving human health worldwide.BETASERON ® INTERFERON BETA -1b gains expanded U.S.
Chiron Corporation - Products - BioPharmaceuticals - Betaseron - FAQ: Pre-Filled Diluent Syringe BETASERON is the first and only FDA-approved interferon therapy that is stable at room temperature for more than 30 days.Betaseron - FAQ: Pre-Filled Diluent Syringe Chiron Corporation - Products - BioPharmaceuticals ...
Chiron Corporation - Patients - Patient Profiles - Betaseron BETASERON ® INTERFERON BETA -1b patient Lisa Eorio, 47, knows the importance of regular exercise and stretching.BETASERON ® Champions of Courage SM grant to underwrite the cost of the entire program.
Chiron Corporation - Products - BioPharmaceuticals - Betaseron - - Enhancing Quality of Life BETASERON ® INTERFERON BETA -1b has established its value for patients with relapsing- remitting multiple sclerosis through its strong clinical message underscored by numerous studies.
Chiron Corporation - Patients - Disease Area Information The following resources have been compiled to help patients and caregivers better understand the illnesses they face and the treatment options available.
Chiron Corporation - Investors - Fact Sheet Through its global Blood Testing, Vaccines and BioPharmaceuticals businesses, Chiron Corporation addresses human suffering with more than 50 diverse products to detect, prevent and treat disease worldwide.
New Therapeutic Options for Established Drugs in Neurological Diseases - - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
author: BioPortfolio - Knowledge Management, Market Analysis and Market Research
cov0345.qxd week 0345 7 Nov 2003 BMS has two applications claiming new pyrrolo- triazine based p38 kinase inhibitors (see page 6) Drug Patenting in Context Supplementary Protection Certificate (SPC) notices this week from the UK Patent Office include two relating to the mid- October entry into force of certificates relating to interferon beta - 1b products.
author: MSparrowhawk
BTECH REGULATORY RADAR - Tracking the Movement of Key Products Through (4 Mar 02) PHASE III INITIATED Schering AG's (NYSE: SHR) Betaseron Schering initiated a multi-center phase III study, BENEFIT (Betaseron / Betaferon in newly emerging multiple sclerosis for initial treatment), designed to evaluate the efficacy and safety of interferon beta -1b (Betaseron, also known as Betaferon) in individuals demonstrating the first clinical...
